Icon - Menu open Search

Advisory Board

Our Advisory Board’s mission is to develop strategic priorities for Canadian cancer research funding, track the cancer research investment, and reinforce the value of cancer research by strengthening its research community through funding partnerships, scientific conferences, and reports.

Representatives of patients and families as well as cancer research funding organizations make up the CCRA Advisory Board.

Dajan O'Donnell Chair

Dajan O’Donnell, PhD, is the Director of Scientific Affairs and Partnerships at the Cancer Research Society (CRS).

 

 

View Past Chairs
resource highlights 02

Patient/Family Representatives

  • Dr. Don Desserud
  • Dr. Rosilene Kraft

Organizational Representatives

  • Dr. Judy Bray, Vice President, Research, Canadian Cancer Society
  • Dr. Helmut Hollenhorst, Senior Medical Director, NSH Cancer Care Program, representing the Canadian Association of Provincial Cancer Agencies
  • Dr. Carole Jabet, Scientific Director, Fonds de recherche du Québec – Santé (FRQS)
  • Dr. Lakshmi Krishnan, Vice President, Life Sciences, National Research Council
  • Dr. Fei-Fei Liu, Scientific Director, CIHR Institute of Cancer Research
  • Ms. Sapna Mahajan, Director, Research and Innovation, Genome Canada
  • Dr. Stéphanie Michaud, President and CEO, BioCanRx
  • Ms. Erika Nicholson, Vice President, Cancer Control, Canadian Partnership Against Cancer
  • Dr. Paul O’Connell, Research Program Lead, The Leukemia & Lymphoma Society of Canada
  • Dr. Dajan O’Donnell, Director, Scientific Partnerships, Cancer Research Society
  • Dr. Paula Robson, Scientific Director, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services
  • Dr. Rebecca Tamarchak, Head, Strategy, Governance and Partnerships, Ontario Institute for Cancer Research
  • Dr. Jim Woodgett, President and Scientific Director, The Terry Fox Research Institute